{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:12:28Z","timestamp":1697274748490},"reference-count":37,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T00:00:00Z","timestamp":1218672000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p>Burkitt's lymphoma and atypical Burkitt\/Burkitt\u2010like lymphoma (BL\/BLL) are considered highly aggressive B\u2010cell lymphomas with a rapid proliferative rate and high rate of apoptosis. The aim of the present study was to confirm whether apoptotic and cell proliferative factors affect BL\/BLL clinical outcomes. We retrospectively analyzed the relationship between the clinical and immunophenotypic features of 43 BL\/BLL patients by immunohistochemical staining for bcl\u20102 and double staining for Ki\u201067 plus caspase\u20103. In double staining experiments, all patients were divided into high and low groups for the expression of caspase\u20103, Ki\u201067, and both Ki\u201067 and caspase\u20103, by using the medians of their percentages as limits. The 43 BL\/BLL patients were divided into high caspase\u20103 (<jats:italic>n<\/jats:italic>\u00a0=\u00a019) and low caspase\u20103 (<jats:italic>n<\/jats:italic>\u00a0=\u00a024) groups. There was a significant difference in the overall survival between the high (77%) and low caspase\u20103 (33%) groups; the survival rate of patients in the low caspase\u20103 group who received aggressive short\u2010term chemotherapy (58%) was significantly better than that of patients who received cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) therapy (17%). All patients positive for bcl\u20102 were in the low caspase\u20103 group (high caspase\u20103 group, 0%; low caspase\u20103 group, 42%). The overall survival tended to be better in the high caspase\u20103 and bcl\u20102\u2010negative group (76%) than in the low caspase\u20103 and bcl\u20102\u2010negative (50%) group. In addition, the low caspase\u20103 and bcl\u20102\u2010positive group tended to show the worst prognosis (16%). We suggest that caspase\u20103 may function as an indicator of the prognosis of BL\/BLL. Furthermore, intensive short\u2010term chemotherapeutic regimens may improve the prognosis of the patients in the low caspase\u20103 group. (<jats:italic>Cancer Sci<\/jats:italic> 2008; 99: 1564\u20131569)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2008.00851.x","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T06:14:36Z","timestamp":1218694476000},"page":"1564-1569","source":"Crossref","is-referenced-by-count":13,"title":["Estimation of the relationship between caspase\u20103 expression and clinical outcome of Burkitt's and Burkitt\u2010like lymphoma"],"prefix":"10.1111","volume":"99","author":[{"given":"Yuko","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morishige","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7696(08)62312-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-364932-4.50010-1"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.10.040192.001411"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400598"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-006-0001-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64779-7"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215540205000401"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400476"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.6.806"},{"key":"e_1_2_6_11_2","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Diebold JJE","year":"2001"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1309\/EQJR3D3V0CCQGP04"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0405"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.21.3707"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc904"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3713"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000019577.73786.64"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00681.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01196.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02196.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65399-0"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02225.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00135.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(03)00371-8"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.15.10905"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.9.6033"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2009"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.05.013"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00183-06"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.06.015"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.12.075"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2004.08.019"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00048059"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-006-6314-5"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04134.x"},{"issue":"1","key":"e_1_2_6_37_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/annonc\/8.suppl_1.S77","article-title":"Eighty\u2010one percent event\u2010free survival in advanced Burkitt's lymphoma\/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol","volume":"8","author":"Todeschini G","year":"1997","journal-title":"Ann Oncol"},{"key":"e_1_2_6_38_2","first-page":"33","article-title":"Additional chemotherapy agents improve treatment outcome for children and adults with advanced B\u2010cell lymphomas","volume":"25","author":"Adde M","year":"1998","journal-title":"Semin Oncol"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2008.00851.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2008.00851.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:45:19Z","timestamp":1697233519000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2008.00851.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1349-7006.2008.00851.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00851.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}